Kako citirati
Sažetak
Uvod. Specifična karakteristika starijih osoba je njihova
krhost /ili fragilnost. Zbog rasprostranjenosti, fragilnost je
potrebno shvatiti kao prioritet javnog zdravlja.
Cilj rada. Ispitati povezanost funkcionalnih i antropometrijskih
parametara sa fragilnošću kod osoba starosti preko
65 godina.
Metod. Istraživanje je dizajnirano kao studija preseka
i obuhvatilo je 446 starijih lica. Kao instrumenti istraživanja
korišćeni su opšti upitnik, za procjenu funkcionalnog statusa
Tinetti test i od antropometrijskih parametara obim nadlaktice
i obim srednje cirkumferencije potkoljenice. Od statističkih
testova koristili smo χ2 test, a Pirsonova (Pearson) korelacijska
analiza korišćena je za analizu korelacije.
Rezultati. Osobe ženskog pola su imale lošiji funkcionalni
status, hod i ravnotežu u odnosu na osobe muškog pola
(χ2=4,125; p<0,127). Uočeno je da su ispitanici muškog pola
imali veće vrijednosti obima nadlaktice (26,96± 3,44) u odnosu
na ženski pol, dok su osobe ženskog pola imale veće vrijednosti
obima srednje cirkumferencije potkoljenice (32,66±
6,29).Analizirajući povezanost antropometrijskih mjerenja sa
ukupnim skorom Tinetti testa i u odnosu na pol ispitanika,
uočeno je da između parametara.postoji korelaciona analiza
Zaključak. Visok procenat ispitanika starijih od 65 godina
ima loš funkcionalni status, kao i niže vrijednosti antropometrijskih
markera, što ukazuje na to da oni mogu biti
potencijalni faktori rizika za nastanak fragilnosti kod osoba
strarijeg životnog doba.
Ključne reči
Array
Array
Array
Reference
Karunananthan S, Wolfson C, Bergman H,
Beland F, Hogan DB. A multidisciplinary
systematic literature review on frailty:
overview of the methodology used by the
Canadian Initiative on Frailty and Aging.
BMC Med Res Methodol 2009;9:68.
Lepeleire JD, IIiffe S, Mann E, IIiffe S,
Mann E, Degryse JM, et al. Frailty: an
emerging concept for general practice. Br
J Gen Pract 2009;59: 177-187.
Rodríguez-Mañas L, Féart C, Mann
G, Viña J, Chatterji S, Chodzko-Zajko
WJ et al. Searching for an operational
definition of frailty: a delphi method based
consensus statement. The frailty operative
definition-consensus conference project.
J Gerontol A Biol Sci Med Sci 2013;68:
-7.
Fedarko NS. The Biology of Aging and
Frailty. Clin Geriatr Med
;27:27–37.
Clegg A; Young J; Iliffe S; Rikkert MO;
Rockwood K. Frailty in elderly people.
Lancet. 2013; 381:752-762.
Xue QL Frailty Syndrome; Definition
and Natural History. Clin Geriatr
Med2011;27:1–15.
Buckinx F, Rolland Y, Reginster JY,
Ricour C, Petermans J, Bruyère O. Burden
of frailty in the elderly population:
perspectives for a public health challenge.
Arch Public Health 2015;73:19.
Gale CR, Cooper C, Sayer AA. Prevalence
of frailty and disability: findings from the
English Longitudinal Study of Ageing.Age
Ageing 2015;44:162–165.
Carneiro JA, Ramos GCF, Barbosa ATF,
Mendonça JMG, Costa FM, Caldeira
AP. Prevalence and factors associated
with frailty in non-institutionalized older
adults. Rev Bras Enferm 2016;69:435-42.
Collard RM, Boter H, Schoevers RA,
Oude Voshaar RC. Prevalence of frailty
in community-dwelling older persons:
a systematic review. J Am Geriatr Soc
;60:1487–1492.
Tinetti ME, Williams TF, Mayewski R.
Fall Risk Index for elderly patients based
onnumber of chronic disabilities. Am J
Med 1986:80:429-434.
Physical status: the use and interpretation
of anthropometry. WHO Expert
Committee Report. World Health Organ
Tech Rep Ser 1995;854:1-452.
Rolland Y, Abellan van Kan G, Gillette-
Guyonnet S, Vellas B. Cachexia versus
sarcopenia. Curr Opin Clin Nutr Metab
Care 2011;14:15–21.
Peterson SJ, Mozer M. Differentiating
sarcopenia and cachexia among patients
with cancer. Nutr Clin Pract 2017;32:
–9.
Saliba D, Elliott M, Rubenstein LZ,
Solomon DH, Young RT, Kamberg CJ, et
al. The Vulnerable Elders Survey: a tool
for identifying vulnerable older people
in the community. J Am Geriatr Soc
;49:1691–9.
Zhang XS, Liu YH, Zhang Y, Xu Q, Yu
Q, Yu Xet al. Handgrip strength as a
predictor of nutritional status in Chinese
elderly inpatients at hospital admission.
Biomed Environ Sci 2017;30:802-10.
Argilés JM, Busquets S, Stemmler
B, López-Soriano FJ. Cachexia and
sarcopenia: mechanisms and potential
targets for intervention. Curr Opin
Pharmacol 2015;22:100–6.
Zdzieblik D, Oesser S, Baumstark
MW, Gollhofer A, König D. Collagen
peptide supplementation in combination
with resistance training improves body
composition and increases muscle strength
in elderly sarcopenic men: a randomised
controlled trial. Br J Nutr 2015;114:
–45.
Chen LK, Liu LK, Woo J, Assantchia
P, Auyeung TW, Bahyah KS, et al.
Sarcopenia in Asia: consensus report of
the Asian Working Group for Sarcopenia. J
Am Med Dir Assoc 2014;15:95-101.
Lee D, Shook RP, Drenowatz C, Blair
SN. Physical activity and sarcopenic
obesity: definition, assessment,
prevalence, and mechanism. Future Sci
OA2016;2:FSO127.
Polyzos SA, Margioris AN. Sarcopenic
obesity. Hormones (Athens, Greece)
;17:321-331.
JafariNasabian P, Inglis JE, Wendimere R,
Kelly OJ, Ilich JZ. Aging human body:
changes in bone, muscle, and body fat with
consequent changes in nutrient intake.J
Endocrinol 2017;234:R37–R51.
Kalinkovich A, Livshits G. Sarcopenic
obesity or obese sarcopenia: a cross talk
between age-associated adipose tissue and
skeletal muscle inflammation as a main
mechanism of the pathogenesis. Ageing
Res Rev2017;35:200–221.
Wannamethee SG, Atkins JL. Muscle
loss and obesity: the health implications of
sarcopenia and sarcopenic obesity. Proc
Nutr Soc2015;74:405–12.
Kwon HJ, Ha YC, Park HM.
The Reference Value of Skeletal
Muscle Mass Index for Defining the
Sarcopenia of Women in Korea. J Bone
Metab2015;22:71-5.
Autori zadržavaju autorska prava nad objavljenim člancima, a izdavaču daju neekskluzivno pravo da članak objavi, da u slučaju daljeg korišćenja članka bude naveden kao njegov prvi izdavač, kao i da distribuira članak u svim oblicima i medijima.